March 23, 2023 |
March 21, 2023 |
PS
Planned sale
|
Francois Cedric
Chief Executive Officer
Executive Director
|
30,000
-2.6%
62.74
1,882,332
USD
|
30,000
-2.6%
|
62.74
|
1,882,332
USD
|
|
March 21, 2023 |
March 17, 2023 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
64.03
80,038
USD
|
1,250
-0.5%
|
64.03
|
80,038
USD
|
|
March 10, 2023 |
March 8, 2023 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
63.79
765,480
USD
|
12,000
-1.2%
|
63.79
|
765,480
USD
|
|
March 7, 2023 |
March 3, 2023 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-6.2%
63.84
319,200
USD
|
5,000
-6.2%
|
63.84
|
319,200
USD
|
|
March 2, 2023 |
March 1, 2023 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
65.33
32,665
USD
|
500
-0.4%
|
65.33
|
32,665
USD
|
|
Feb. 27, 2023 |
Feb. 23, 2023 |
PS
Planned sale
|
Lewis Karen
Chief People Officer
Officer
|
1,104
-2.6%
68.76
75,911
USD
|
1,104
-2.6%
|
68.76
|
75,911
USD
|
|
Feb. 27, 2023 |
Feb. 23, 2023 |
PS
Planned sale
|
Eisele Jeffrey
Chief Development Officer
Officer
|
1,646
-3.0%
68.76
113,179
USD
|
1,646
-3.0%
|
68.76
|
113,179
USD
|
|
Feb. 21, 2023 |
Feb. 17, 2023 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
52.38
65,475
USD
|
1,250
-0.5%
|
52.38
|
65,475
USD
|
|
Feb. 10, 2023 |
Feb. 8, 2023 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
54.45
653,400
USD
|
12,000
-1.2%
|
54.45
|
653,400
USD
|
|
Feb. 6, 2023 |
Feb. 3, 2023 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-6.9%
55.85
279,250
USD
|
5,000
-6.9%
|
55.85
|
279,250
USD
|
|
Feb. 2, 2023 |
Feb. 1, 2023 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
52.61
26,305
USD
|
500
-0.4%
|
52.61
|
26,305
USD
|
|
Jan. 31, 2023 |
Jan. 30, 2023 |
PS
Planned sale
|
Lewis Karen
Chief People Officer
Officer
|
883
-2.4%
52.76
46,587
USD
|
883
-2.4%
|
52.76
|
46,587
USD
|
|
Jan. 31, 2023 |
Jan. 30, 2023 |
PS
Planned sale
|
Eisele Jeffrey
Chief Development Officer
Officer
|
883
-1.9%
52.76
46,587
USD
|
883
-1.9%
|
52.76
|
46,587
USD
|
|
Jan. 25, 2023 |
Jan. 23, 2023 |
PS
Planned sale
|
Lewis Karen
Chief People Officer
Officer
|
2,955
-7.3%
51.58
152,419
USD
|
2,955
-7.3%
|
51.58
|
152,419
USD
|
|
Jan. 25, 2023 |
Jan. 23, 2023 |
PS
Planned sale
|
Eisele Jeffrey
Chief Development Officer
Officer
|
4,479
-8.6%
51.58
231,027
USD
|
4,479
-8.6%
|
51.58
|
231,027
USD
|
|
Jan. 19, 2023 |
Jan. 17, 2023 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
52.42
65,525
USD
|
1,250
-0.5%
|
52.42
|
65,525
USD
|
|
Jan. 10, 2023 |
Jan. 9, 2023 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
46.08
552,960
USD
|
12,000
-1.2%
|
46.08
|
552,960
USD
|
|
Jan. 9, 2023 |
Jan. 5, 2023 |
PS
Planned sale
|
Grossi Federico
Chief Medical Officer
Officer
|
2,500
-2.6%
48.79
121,975
USD
|
2,500
-2.6%
|
48.79
|
121,975
USD
|
|
Jan. 5, 2023 |
Jan. 3, 2023 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
50.70
25,350
USD
|
500
-0.4%
|
50.70
|
25,350
USD
|
|
Jan. 5, 2023 |
Jan. 3, 2023 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
50.70
253,500
USD
|
5,000
-10.4%
|
50.70
|
253,500
USD
|
|
Dec. 21, 2022 |
Dec. 19, 2022 |
PS
Planned sale
|
Francois Cedric
Chief Executive Officer
Executive Director
|
24,449
-2.5%
52.07
1,273,052
USD
|
24,449
-2.5%
|
52.07
|
1,273,052
USD
|
|
Dec. 21, 2022 |
Dec. 19, 2022 |
PS
Planned sale
|
Francois Cedric
Chief Executive Officer
Executive Director
|
3,751
-0.4%
51.97
194,931
USD
|
3,751
-0.4%
|
51.97
|
194,931
USD
|
|
Dec. 19, 2022 |
Dec. 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
52.35
65,438
USD
|
1,250
-0.5%
|
52.35
|
65,438
USD
|
|
Dec. 12, 2022 |
Dec. 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
47.50
570,000
USD
|
12,000
-1.2%
|
47.50
|
570,000
USD
|
|
Dec. 7, 2022 |
Dec. 5, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
50.38
251,900
USD
|
5,000
-10.4%
|
50.38
|
251,900
USD
|
|
Dec. 2, 2022 |
Dec. 1, 2022 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
49.93
24,965
USD
|
500
-0.4%
|
49.93
|
24,965
USD
|
|
Dec. 2, 2022 |
Dec. 1, 2022 |
PS
Planned sale
|
Grossi Federico
Chief Medical Officer
Officer
|
2,500
-2.5%
49.93
124,825
USD
|
2,500
-2.5%
|
49.93
|
124,825
USD
|
|
Nov. 17, 2022 |
Nov. 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
48.01
60,013
USD
|
1,250
-0.5%
|
48.01
|
60,013
USD
|
|
Nov. 10, 2022 |
Nov. 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
46.47
557,640
USD
|
12,000
-1.2%
|
46.47
|
557,640
USD
|
|
Nov. 7, 2022 |
Nov. 3, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
58.54
292,700
USD
|
5,000
-10.4%
|
58.54
|
292,700
USD
|
|
Nov. 3, 2022 |
Nov. 1, 2022 |
PS
Planned sale
|
Grossi Federico
Chief Medical Officer
Officer
|
2,500
-2.4%
60.83
152,075
USD
|
2,500
-2.4%
|
60.83
|
152,075
USD
|
|
Nov. 3, 2022 |
Nov. 1, 2022 |
PS
Planned sale
|
Dunlop A. Sinclair
Non-Executive Director
|
500
-0.4%
60.83
30,415
USD
|
500
-0.4%
|
60.83
|
30,415
USD
|
|
Oct. 17, 2022 |
Oct. 14, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
59.31
74,138
USD
|
1,250
-0.5%
|
59.31
|
74,138
USD
|
|
Oct. 11, 2022 |
Oct. 10, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
57.50
690,000
USD
|
12,000
-1.2%
|
57.50
|
690,000
USD
|
|
Oct. 5, 2022 |
Oct. 3, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
66.69
333,450
USD
|
5,000
-10.4%
|
66.69
|
333,450
USD
|
|
Oct. 5, 2022 |
Oct. 3, 2022 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.4%
66.69
166,725
USD
|
2,500
-2.4%
|
66.69
|
166,725
USD
|
|
Sept. 16, 2022 |
Sept. 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
66.00
82,500
USD
|
1,250
-0.5%
|
66.00
|
82,500
USD
|
|
Sept. 12, 2022 |
Sept. 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.2%
63.98
767,760
USD
|
12,000
-1.2%
|
63.98
|
767,760
USD
|
|
Sept. 8, 2022 |
Sept. 8, 2022 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
15,000
-5.9%
65.00
975,000
USD
|
15,000
-5.9%
|
65.00
|
975,000
USD
|
|
Sept. 7, 2022 |
Sept. 6, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
60.38
301,900
USD
|
5,000
-10.4%
|
60.38
|
301,900
USD
|
|
Sept. 2, 2022 |
Sept. 1, 2022 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.3%
60.30
150,750
USD
|
2,500
-2.3%
|
60.30
|
150,750
USD
|
|
Aug. 18, 2022 |
Aug. 17, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
69.50
347,500
USD
|
5,000
-14.6%
|
69.50
|
347,500
USD
|
|
Aug. 16, 2022 |
Aug. 15, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
69.00
862,500
USD
|
12,500
-22.6%
|
69.00
|
862,500
USD
|
|
Aug. 16, 2022 |
Aug. 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
67.21
84,013
USD
|
1,250
-0.5%
|
67.21
|
84,013
USD
|
|
Aug. 12, 2022 |
Aug. 11, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
67.00
837,500
USD
|
12,500
-22.6%
|
67.00
|
837,500
USD
|
|
Aug. 12, 2022 |
Aug. 11, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
67.00
335,000
USD
|
5,000
-14.6%
|
67.00
|
335,000
USD
|
|
Aug. 12, 2022 |
Aug. 11, 2022 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
30,000
-10.5%
65.63
1,968,900
USD
|
30,000
-10.5%
|
65.63
|
1,968,900
USD
|
|
Aug. 9, 2022 |
Aug. 8, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
64.50
322,500
USD
|
5,000
-14.6%
|
64.50
|
322,500
USD
|
|
Aug. 9, 2022 |
Aug. 8, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
12,500
-22.6%
65.00
812,500
USD
|
12,500
-22.6%
|
65.00
|
812,500
USD
|
|
Aug. 9, 2022 |
Aug. 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
62.50
750,000
USD
|
12,000
-1.3%
|
62.50
|
750,000
USD
|
|
Aug. 8, 2022 |
Aug. 4, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
62.00
310,000
USD
|
5,000
-14.6%
|
62.00
|
310,000
USD
|
|
Aug. 8, 2022 |
Aug. 4, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-12.7%
59.50
297,500
USD
|
5,000
-12.7%
|
59.50
|
297,500
USD
|
|
Aug. 4, 2022 |
Aug. 3, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-11.7%
56.43
282,150
USD
|
5,000
-11.7%
|
56.43
|
282,150
USD
|
|
Aug. 2, 2022 |
Aug. 1, 2022 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.3%
55.99
139,975
USD
|
2,500
-2.3%
|
55.99
|
139,975
USD
|
|
July 28, 2022 |
July 27, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
57.00
285,000
USD
|
5,000
-14.6%
|
57.00
|
285,000
USD
|
|
July 21, 2022 |
July 19, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
5,000
-14.6%
56.42
282,100
USD
|
5,000
-14.6%
|
56.42
|
282,100
USD
|
|
July 18, 2022 |
July 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
46.33
57,913
USD
|
1,250
-0.5%
|
46.33
|
57,913
USD
|
|
July 12, 2022 |
July 11, 2022 |
PS
Planned sale
|
Townsend Adam J.
Chief Commercial Officer
Officer
|
5,000
-10.4%
48.42
242,100
USD
|
5,000
-10.4%
|
48.42
|
242,100
USD
|
|
July 12, 2022 |
July 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
47.95
575,400
USD
|
12,000
-1.3%
|
47.95
|
575,400
USD
|
|
June 29, 2022 |
June 27, 2022 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
1,341
-50.0%
46.79
62,743
USD
|
1,341
-50.0%
|
46.79
|
62,743
USD
|
|
June 24, 2022 |
June 23, 2022 |
S
Sale
|
Dunlop A. Sinclair
Non-Executive Director
|
15,000
-5.0%
45.00
675,000
USD
|
15,000
-5.0%
|
45.00
|
675,000
USD
|
|
June 23, 2022 |
June 22, 2022 |
S
Sale
|
Watson David O.
General Counsel
Officer
|
10,000
-8.0%
44.51
445,140
USD
|
10,000
-8.0%
|
44.51
|
445,140
USD
|
|
June 22, 2022 |
June 17, 2022 |
S
Sale
|
Brown Victoria L.
Program Team Lead
Officer
|
2,698
-9.7%
45.00
121,410
USD
|
2,698
-9.7%
|
45.00
|
121,410
USD
|
|
June 21, 2022 |
June 16, 2022 |
S
Sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
10,000
-25.5%
41.79
417,850
USD
|
10,000
-25.5%
|
41.79
|
417,850
USD
|
|
June 17, 2022 |
June 15, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
39.29
49,113
USD
|
1,250
-0.5%
|
39.29
|
49,113
USD
|
|
June 9, 2022 |
June 8, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
12,000
-1.3%
44.09
529,080
USD
|
12,000
-1.3%
|
44.09
|
529,080
USD
|
|
June 2, 2022 |
June 1, 2022 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.2%
41.78
104,450
USD
|
2,500
-2.2%
|
41.78
|
104,450
USD
|
|
May 31, 2022 |
May 27, 2022 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
10,000
-19.9%
43.00
430,000
USD
|
10,000
-19.9%
|
43.00
|
430,000
USD
|
|
May 17, 2022 |
May 16, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
39.18
48,975
USD
|
1,250
-0.5%
|
39.18
|
48,975
USD
|
|
May 3, 2022 |
May 2, 2022 |
PS
Planned sale
|
Grossi Federico
CHIEF MEDICAL OFFICER
Officer
|
2,500
-2.2%
43.56
108,900
USD
|
2,500
-2.2%
|
43.56
|
108,900
USD
|
|
May 2, 2022 |
April 29, 2022 |
PS
Planned sale
|
Deschatelets Pascal
Chief Scientific Officer
Officer
|
4,000
-0.4%
44.43
177,720
USD
|
4,000
-0.4%
|
44.43
|
177,720
USD
|
|
April 27, 2022 |
April 25, 2022 |
PS
Planned sale
|
Watson David O.
General Counsel
Officer
|
5,000
-3.8%
50.00
250,000
USD
|
5,000
-3.8%
|
50.00
|
250,000
USD
|
|
April 22, 2022 |
April 20, 2022 |
PS
Planned sale
|
DeLong Mark Jeffrey
Senior Vice President
Officer
|
7,000
-19.7%
52.53
367,710
USD
|
7,000
-19.7%
|
52.53
|
367,710
USD
|
|
April 18, 2022 |
April 14, 2022 |
PS
Planned sale
|
Machiels Alec
Non-Executive Director
|
1,250
-0.5%
50.90
63,625
USD
|
1,250
-0.5%
|
50.90
|
63,625
USD
|
|
April 6, 2022 |
April 5, 2022 |
PS
Planned sale
|
SCHEIBLER LUKAS
CHIEF INNOVATION OFFICER
Officer
|
609
-1.2%
60.09
36,593
USD
|
609
-1.2%
|
60.09
|
36,593
USD
|
|